hexamethonium has been researched along with Carcinoma, Small Cell in 1 studies
Hexamethonium: A nicotinic cholinergic antagonist often referred to as the prototypical ganglionic blocker. It is poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier. It has been used for a variety of therapeutic purposes including hypertension but, like the other ganglionic blockers, it has been replaced by more specific drugs for most purposes, although it is widely used a research tool.
Carcinoma, Small Cell: An anaplastic, highly malignant, and usually bronchogenic carcinoma composed of small ovoid cells with scanty neoplasm. It is characterized by a dominant, deeply basophilic nucleus, and absent or indistinct nucleoli. (From Stedman, 25th ed; Holland et al., Cancer Medicine, 3d ed, p1286-7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sorenson, GD | 1 |
| Pettengill, OS | 1 |
| Cate, CC | 1 |
| Ghatei, MA | 1 |
| Molyneux, KE | 1 |
| Gosselin, EJ | 1 |
| Bloom, SR | 1 |
1 other study available for hexamethonium and Carcinoma, Small Cell
| Article | Year |
|---|---|
Bombesin and calcitonin secretion by pulmonary carcinoma is modulated by cholinergic receptors.
Topics: Acetylcholine; Atropine; Bethanechol; Bethanechol Compounds; Bombesin; Calcitonin; Carbachol; Carcin | 1983 |